Panel on Biomedical Innovation Policy at Mount Sinai on Monday, June 1st at 5:30pm

What: Biomedical Innovation: Current Issues and Potential Solutions with Perspectives from Academia and Public Policy

Who: Open to the public - please distribute widely!

When: Monday, June 1st at 5:30pm

Where: Goldwurm Auditorium, Icahn Building, 1425 Madison Avenue

(More extended bios are at the end of the email) Our panelists include:

• Moderator: Dennis Charney - Dean of MSSM; Professor of Psychiatry
• Kenneth Davis - President/CEO of the Mount Sinai Medical Center; Professor of Psychiatry
• Brook Baker - Professor of Law, Northeastern University; Co-chair of HealthGAP; Consultant to African Union, WHO, ASEAN
• Bhaven Sampat – Assistant Professor, Department of Health Policy and Management, Columbia’s School of International and Public Affairs
• Jamie Love – Director of Knowledge Ecology International; Advisor to the X-Prize Foundation; Member of MSF Working Group on Intellectual Property
• Robert Desnick – Chairman of Department of Human Genetics, Mount Sinai; Director of Institute for Genomic Sciences, Mount Sinai; Scientific founder of Amicus Therapeutics
  

OPEN TO THE PUBLIC (please distribute widely)

Sponsored by: Universities Allied for Essential Medicines, AMSA, Department of Medical Education

The full story behind this panel:

About a month ago, Sinai President/CEO Ken Davis wrote an editorial advertisement advocating for longer patent monopolies for pharmaceuticals.

A group of students and faculty voiced concern with this policy given the implications for increased healthcare costs and for decreased access to medicines.

The general questions to these: Drug companies have a drought in their research pipelines. Millions of underinsured/uninsured Americans and billions in developing countries struggle for access to life-saving and quality of life improving medicines. What are the goals of biomedical research? Whom should it benefit? How mechanisms are effective? What can be done by governments, universities, and companies to achieve this?

DETAILS again:

June 1^st 5:30pm (come a few minute early to pick up food) at Goldwurm Auditorium in the Icahn building

THIS EVENT IS OPEN TO THE PUBLIC – please invite any and all

This panel is cosponsored by Universities Allied for Essential Medicine (UAEM), AMSA, and the Department of Medical Education

Kenneth Davis’s research on Alzheimer led to the development of cholinesterase inhibitors that effectively treat the symptoms of the disease. He demonstrated dopamine’s importance in the pathogenesis of schizophrenia. Currently he is the CEO and President of the Mount Sinai Medical Center. Link to extended biography

Dennis Charney is one of the world's leading experts on the neurobiology and treatment of serious mood and anxiety disorders. As Dean of the Mount Sinai School of Medicine, he increased the school’s focus on translational research and has led an increase in the amount of NIH funding that the school receives. Link to extended biography

Brook Baker is a legal scholar with expertise on intellectual property rights, health financing, and access to medicines. He is co-chair and policy analyst for Health GAP (Global Access Project). He has consulted for the African Union, ASEAN, Venezuela, CARICOM, Thailand, DfID, the World Health Organization, the Millennium Development Goals Project and others. He works on policy issues concerning the Global Fund to Fight AIDS, Tuberculosis and Malaria and the US PEPFAR Program. Link to extended biography

Bhaven Sampat is an economist by training and is an expert on the intersection of health policy and innovation policy. His current projects examine the impacts of new global patent laws on innovation and access to medicines in developing countries, the political economy of the National Institutes of Health, the roles of the public and private sectors in pharmaceutical innovation, and institutional aspects of patent systems. Dr. Sampat has also written extensively on the effects of university patenting and "entrepreneurship" on academic medicine. He is recipient of a Robert Wood Johnson Foundation "Investigator Award" to study how the NIH allocates its funds across disease areas. Link to extended biography

James Love is the Director of Knowledge Ecology International which received a MacArthur Award for Creative and Effective Institutions in 2006. He advises UN agencies, national governments, international and regional intergovernmental organizations and public health NGOs, and is the author of a number of articles and monographs on innovation and intellectual property rights. Mr. Love is also the U.S. co-chair of the Trans-Atlantic Consumer Dialogue (TACD) Working Group on Intellectual Property, chair of Essential Inventions, an advisor to the X-Prize Foundation on a prize for TB diagnostics, and a member of the UNITAID Expert Group on Patent Pools, the MSF Working Group on Intellectual Property, the Stop-TB Partnership working group on new drug development, and the Internet Governance Forum (IGF) Dynamic Coalition on Open Standards. Link to extended biography

Robert Desnick is a professor and chair of the Department of Genetics and Genomics Sciences at Mount Sinai. He is a fellow of the American Academy for the Advancement of Science and a member of the Institute of Medicine of the National Academy of Sciences He is a past chair of the Association of American Medical Colleges. He is the scientific founder and a consultant to Amicus Therapeutics, Inc. He is a consultant and has a licensed patent for agalsidase beta with Genzyme Corp.